Edward Hurwitz, a venture partner of Alta Partners, has joined the board of directors of Mountain View, Calif.-based Aclara Biosciences. From 1997 to 2001, he was senior vice president and CFO of Affymetrix. Hurwitz holds JD and MBA degrees from the University of California, Berkeley, and a BA in molecular biology from Cornell University.
Brent Kreider has become senior vice president of cell-based microarray company Akceli in Cambridge, Mass. Kreider joins the company from Lexington, Mass.-based Phylos, where he was vice president of biological research. Prior to that, Kreider was a cell biologist and associate director at Human Genome Sciences. He holds a BS in microbiology from Penn State University and a PhD in molecular/microbiology from the University of Pennsylvania.
Frank Witney has become CEO of microarray startup GenoSpectra in Fremont, Calif., joining the company from PerkinElmer Life Sciences, where he was president. Prior to that, he served as president and COO of Packard BioScience. Previously, he was group operations manager of the life science group at Bio-Rad Laboratories. Witney holds a doctorate in molecular and cell biology from Indiana University.